Study to Evaluate CCS1477 in Advanced Tumours

NCT03568656 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-Resistant Prostate Cancer
Metastatic Breast Cancer
Non-small Cell Lung Cancer
Advanced Solid Tumors

Interventions

DRUG: CCS1477
DRUG: Abiraterone acetate
DRUG: Enzalutamide
DRUG: Darolutamide
DRUG: Olaparib
DRUG: Atezolizumab

Sponsor

CellCentric Ltd.